Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)
Japan flag Japan · Delayed Price · Currency is JPY
97.00
+2.00 (2.11%)
Apr 17, 2026, 3:30 PM JST

TYO:4596 Income Statement

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2127398-
Revenue Growth (YoY)
-22.22%-30.77%387.50%--
Cost of Revenue
265125-
Gross Profit
-522273-
Selling, General & Admin
543711633602604
Research & Development
3105437881,5122,040
Other Operating Expenses
-1110--
Operating Expenses
8531,2551,5312,1142,644
Operating Income
-858-1,233-1,504-2,111-2,644
Interest Expense
--7-9-11-18
Interest & Investment Income
15131811
Other Non Operating Income (Expenses)
21715118935
EBT Excluding Unusual Items
-640-1,220-1,489-2,015-2,616
Gain (Loss) on Sale of Assets
--56---
Asset Writedown
-36-56---
Pretax Income
-676-1,332-1,489-2,015-2,616
Net Income
-676-1,332-1,489-2,015-2,616
Net Income to Common
-676-1,332-1,489-2,015-2,616
Shares Outstanding (Basic)
6456564946
Shares Outstanding (Diluted)
6456564946
Shares Change (YoY)
13.32%1.35%12.85%8.19%6.30%
EPS (Basic)
-10.59-23.64-26.78-40.90-57.45
EPS (Diluted)
-10.59-23.65-26.79-40.92-57.46
Free Cash Flow
-593-1,244-1,401-2,143-2,521
Free Cash Flow Per Share
-9.29-22.08-25.20-43.50-55.36
Gross Margin
-23.81%81.48%69.23%37.50%-
Operating Margin
-4085.71%-4566.67%-3856.41%-26387.50%-
Profit Margin
-3219.05%-4933.33%-3817.95%-25187.50%-
Free Cash Flow Margin
-2823.81%-4607.41%-3592.31%-26787.50%-
EBITDA
-793-1,168-1,417-2,053-2,585
D&A For EBITDA
6565875859
EBIT
-858-1,233-1,504-2,111-2,644
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.